aap
-
Biologics
aap concludes distribution contract with leading US healthcare service provider
aap Implantate AG (“aap”) announces the conclusion of a distribution contract for its LOQTEQ® products with a leading US healthcare service…
Read More » -
Extremities
aap: LOQTEQ® VA Distal Radius System has clinically proven and receives high level of market acceptance
Press Release dated October 18, 2016 The evaluation following the market launch one year ago shows that the LOQTEQ® VA…
Read More » -
Extremities
aap: Market launch of innovative periprosthetic LOQTEQ® system
October 14, 2016 aap Implantate AG (“aap”) announces the market launch of its innovative periprosthetic LOQTEQ® system with the distal lateral…
Read More » -
Financial
aap Implantate AG – Q2/2016 sales and EBITDA at upper end of guidance; further important progress with LOQTEQ® and Silver Technology
Press Release dated August 12, 2016 Sales and EBITDA in Q2/2016 at EUR 3.4 million (guidance: EUR 2.5 million to…
Read More » -
Financial
aap completes sale of biomaterials business
aap Implantate AG (“aap”) today completed the sale of 100% of the company shares in its subsidiary aapBiomaterials GmbH. The…
Read More » -
Financial
aap sells Biomaterials Business for EUR 36 Million and becomes a pure player in trauma with innovative technologies
Press Release dated March 22, 2016 aap Implantate AG (“aap”) signed a notarized share purchase agreement today with a leading…
Read More » -
Hospitals
aap´s silver coating patent receives notice of allowance by US Patent and Trademark office
aap Implantate AG (XETRA: AAQ.DE) announced today that the United States Patent and Trademark Office (USPTO) has issued the notice…
Read More » -
Integra LifeSciences Announces Contract With aap Implantate AG to Provide Stainless Headed Compression Screws for Mid and Hindfoot Reconstruction
PLAINSBORO, N.J. and BERLIN, Jun 21, 2012 (GlobeNewswire via COMTEX) — Integra LifeSciences Holdings Corporation IART +1.01% today announced that it will feature…
Read More » -
aap Implantate AG Licenses Proprietary Biomaterials Product to a World Leading Medical Technology Company
Berlin, Germany March 28, 2012 – aap Implantate AG (XETRA: AAQ.DE), a global medical device company focused on innovative trauma products and biomaterials…
Read More » -
Consistent implementation of strategic focus continues to bear fruit with aap reporting 10% sales growth and EBITDA up by 54% in H1 2011
aap Implantate AG, a medical technology company listed in the Prime Segment of the Frankfurt Stock Exchange, reports for the first-half…
Read More » -
aap implante- Q1 Sales EUR 5.7 Million, Management Team Enlarged
aap Implantate AG, a medical technology company listed in the Prime Standard segment of the Frankfurt Stock Exchange, achieved in…
Read More » -
aap reports Nine-Month Sales of EUR 25.6 million (+6%), EBITDA EUR 5.6 million (+51%)
aap Implantate AG, a medical technology company specialized in medical biomaterials, fracture healing and joint replacement that is listed in…
Read More »